Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DIVALPROEX SODIUM
- Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite
- Comparative Study Between Valproate and Memantine in the Prophylactic Management of Episodic Migraine.
- Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
- Gabapentin for Alcohol Withdrawal Syndrome
- Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma
- Intervention Study for Individuals With Compulsive Sexual Behavior
- Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
- Treatment of Children With Autism Spectrum Disorders and Epileptiform EEG With Divalproex Sodium
- Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood Swings
- A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous Histamine Dihydrochloride for Migraine Prophylaxis
- A Study in Stable Epilepsy Patients Comparing Brand and Generic Divalproex Sodium Extended Release Tablets
- Valproate for Mood Swings and Alcohol Use Following Head Injury
- Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
- Bioequivalence Study of Divalproex Sodium ER Tablets, 500 mg Under Fed Conditions
- Bioequivalence Study of Divalproex Sodium ER Tablets 500 mg of Dr. Reddy's Under Fasting Conditions
- Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
- Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
- Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
- Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
- Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg
- A Study of Divalproex Sodium in Children With ASD and Epileptiform EEG
- Bioequivalence Study of Divalproex Sodium DR Tablets 500 mg of Dr. Reddy's Under Fed Conditions
- Bioequivalence Study of Divalproex Sodium Capsules(Sprinkle),125 mg of Dr. Reddy's Under Fasting Condition (Apple Sauce)
- Bioequivalency Study of Divalproex Sodium DR Tablets, 500 mg of Dr.Reddy's Under Fasting Conditions
- A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder
- A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition
- Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions
- Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions
- Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions
- To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions
- Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions
- Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions
- Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions
- Food Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
- Fasting Study of Divalproex Sodium Extended-Release Tablets 500 mg to Depakote ER® Tablets 500 mg
- Pediatric Switch Study for Children and Adolescent Patients With Epilepsy
- Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
- Tolerability and Efficacy of Depakote-extended Release in the Elderly
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
- Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?
- Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Allocation
- Valproate Efficacy in Cocaine-Bipolar Comorbidity
- Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder
- Divalproex Sodium (Depakote) for Explosive Tempers in Adolescents and Adults
- Effectiveness of Divalproex Sodium (Depakote) in Treating Children With Temper Outbursts and Severe Mood Swings
- Divalproex Sodium ER in Adult Autism
- Divalproex Sodium vs. Placebo in Childhood/Adolescent Autism
- Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
- Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder
- Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
- Safety And Efficacy Study Of Depakote ER To Treat Pediatric Bipolar Disorder
- Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
- Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Mania Associated With Bipolar Disorder in Children and Adolescents
- A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER in Subjects Who Either Completed or Prematurely Discontinued Due to Ineffectiveness From Study M02-488.
- The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
- Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar II Depression
- Depakote ER in Bipolar Depression
- Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipolar Disorder
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric Bipolar
- 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786)
- 12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008 / P05844 / MK-8274-017)
- Valnoctamide in Mania
- Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder
- An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and Adolescents
Clinical trials list
click for details